Novel stereoselective synthesis of benzimidazole sulfoxides
AssigneeHetero Drugs Limited
InventorsBandi Reddy, Kura Reddy, Rapolu Reddy, Dasari Reddy
Life of this patent
Estimating the term…
Loading patent…
AssigneeHetero Drugs Limited
InventorsBandi Reddy, Kura Reddy, Rapolu Reddy, Dasari Reddy
Estimating the term…
The present invention relates to a process for stereoselective synthesis of substituted sulfoxides either as a single enantiomer or in an enantiomerically enriched form. Thus, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]-1H-benzimidazole is reacted with (R)-camphorsulfonyl chloride to form a mixture of 1-(R)-camphorsulfonyl-5- (and 6-)methoxy-2-[(3,5-dimethyl-4-methoxy-2-pyridyl)methylthio]-1H-benzimidazole, oxidized to obtain a diastereomeric excess of 1-(R)-camphorsulfonyl-(5- and 6-)-methoxy-2-[(3,5-dimethyl-4-methoxy-2-pyridyl)methyl-(S)-sulfinyl]-1H-benzimidazole over 1-(R)-camphorsulfonyl-(5- and 6-)-methoxy-2-[(3,5-dimethyl-4-methoxy-2-pyridyl)methyl-(R)-sulfinyl]-1H-benzimidazole, the diastereomers are separated by fractional crystallization and the separated 1-(R)-camphorsulfonyl-(5- and 6-)-methoxy-2-[(3,5-dimethyl-4-methoxy-2-pyridyl)methyl-(S)-sulfinyl]-1H-benzimidazole is deprotected to give esomeprazole.
1-92. (canceled)
Substantially pure compounds of formula VIa to VId:
(canceled)
(canceled)
(canceled)
Benzimidazole sulfides of formula IV:
Compounds of formula IVa and IVb in substantially pure form:
Dependencies are inferred from the claim text.